Sun Pharmaceutical Industries Limited
NSE: SUNPHARMA BSE: SUNPHARMA
NSE
1,710.10
-14.30 (-0.83%)
Prev Close
1724.4
Open Price
1722.2
Volume
1,143,448
Today Low / High
1710 / 1727
52 WK Low / High
1548 / 1851.2
Range
1,625 - 1,796
BSE
1,710.00
-14.30 (-0.83%)
Prev Close
1724.3
Open Price
1723.5
Volume
23,270
Today Low / High
1710 / 1727.15
52 WK Low / High
1547.25 / 1850.95
Range
1,625 - 1,796
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 1710.1 (target range: 1,625 - 1,796), reflecting a change of -14.3 (-0.82927%). On the BSE, it is listed at 1710 (target range: 1,625 - 1,796), showing a change of -14.3 (-0.82932%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
19 Feb
1,722.20
-0.51%
18 Feb
1,720.40
0.23%
17 Feb
1,696.00
1.24%
16 Feb
1,697.50
0.18%
13 Feb
1,714.90
-1.01%
12 Feb
1,714.80
0.01%
11 Feb
1,715.00
-0.23%
10 Feb
1,709.60
-0.11%
09 Feb
1,706.70
-0.12%
06 Feb
1,709.00
-0.81%
05 Feb
1,699.00
0.21%
04 Feb
1,714.90
-0.61%
03 Feb
1,709.90
-0.46%
02 Feb
1,634.00
-0.37%
01 Feb
1,640.00
-1.82%
30 Jan
1,589.30
0.38%
29 Jan
1,625.00
-2.20%
28 Jan
1,639.90
-1.79%
27 Jan
1,658.20
-1.16%
23 Jan
1,640.00
-0.49%
22 Jan
1,614.10
1.25%
Sun Pharmaceutical Industries Limited Graph
Sun Pharmaceutical Industries Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Sun Pharmaceutical Industries Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,710.10, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 1,710.00 | 1,727.10 | 1,554.39 - 1,899.81 |
| 1,744.20 | 1,395.36 - 2,093.04 | ||
| 1,761.30 | 1,232.91 - 2,289.69 | ||
| Bearish Scenario | 1,710.00 | 1,692.90 | 1,523.61 - 1,862.19 |
| 1,675.80 | 1,340.64 - 2,010.96 | ||
| 1,658.70 | 1,161.09 - 2,156.31 |
Overview of Sun Pharmaceutical Industries Limited
ISIN
INE044A01036
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
2,354,950
Market Cap
4,103,102,732,197
Last Dividend
16.5
Official Website
IPO Date
1996-01-01
DCF Diff
186.30
DCF
1,504
Financial Ratios Every Investor Needs
Stock Dividend of SUNPHARMA
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2026-02-05 | February 05, 26 | 11 | 11 | 2026-02-05 | 2026-02-16 | |
| 2025-07-07 | July 07, 25 | 5.5 | 5.5 | 2025-07-07 | 2025-08-08 | |
| 2025-02-06 | February 06, 25 | 10.5 | 10.5 | 2025-02-06 | 2025-02-20 | |
| 2024-07-12 | July 12, 24 | 5 | 5 | 2024-07-12 | 2024-08-16 | |
| 2024-02-09 | February 09, 24 | 8.5 | 8.5 | 2024-02-09 | 2024-02-23 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 52,578.44 Cr | 11,558.45 Cr | 41,019.99 Cr | 0.7802 | 3,154.19 Cr | 0.00 Cr | 27,814.94 Cr | 10,929.04 Cr | 45.60 | 14,967.94 Cr | 0.2079 |
| 2024-03-31 | 48,496.85 Cr | 11,442.18 Cr | 37,054.67 Cr | 0.7641 | 3,127.70 Cr | 0.00 Cr | 24,424.48 Cr | 9,576.38 Cr | 39.91 | 12,876.00 Cr | 0.1975 |
| 2023-03-31 | 43,885.68 Cr | 11,318.67 Cr | 32,567.01 Cr | 0.7421 | 2,307.72 Cr | 0.00 Cr | 21,904.39 Cr | 8,473.58 Cr | 35.32 | 11,651.32 Cr | 0.1931 |
| 2022-03-31 | 38,654.49 Cr | 10,876.14 Cr | 27,778.35 Cr | 0.7186 | 2,132.51 Cr | 0.00 Cr | 18,291.47 Cr | 3,272.73 Cr | 13.64 | 10,153.57 Cr | 0.0847 |
| 2021-03-31 | 33,498.14 Cr | 9,218.52 Cr | 24,279.62 Cr | 0.7248 | 2,102.82 Cr | 0.00 Cr | 15,272.59 Cr | 2,903.82 Cr | 12.10 | 8,345.11 Cr | 0.0867 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 11,331.62 Cr | 92,100.58 Cr | 19,614.63 Cr | 72,218.0200 Cr | 2,362.19 Cr | -8,969.43 Cr | 10,243.33 Cr | 11,270.28 Cr | 0.00 Cr | 376.74 Cr | 4,697.70 Cr | 18,194.2100 Cr |
| 2024-03-31 | 9,285.65 Cr | 85,462.88 Cr | 18,356.91 Cr | 63,666.7500 Cr | 3,273.67 Cr | -6,011.98 Cr | 10,294.89 Cr | 11,300.05 Cr | 126.54 Cr | 489.37 Cr | 6,441.23 Cr | 16,984.4000 Cr |
| 2023-03-31 | 4,623.73 Cr | 80,743.59 Cr | 21,428.12 Cr | 55,995.3800 Cr | 6,889.66 Cr | 2,265.93 Cr | 10,513.05 Cr | 11,353.73 Cr | 7,256.18 Cr | 569.87 Cr | 5,547.05 Cr | 19,906.3800 Cr |
| 2022-03-31 | 4,508.25 Cr | 69,799.87 Cr | 18,733.76 Cr | 48,011.2200 Cr | 1,290.30 Cr | -3,217.95 Cr | 9,239.16 Cr | 11,168.89 Cr | 11,402.24 Cr | 618.75 Cr | 5,278.68 Cr | 17,200.5500 Cr |
| 2021-03-31 | 6,273.03 Cr | 67,666.73 Cr | 18,186.90 Cr | 46,462.7800 Cr | 3,868.58 Cr | -2,404.45 Cr | 9,361.80 Cr | 11,171.51 Cr | 8,687.82 Cr | 718.55 Cr | 6,482.39 Cr | 16,145.6300 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 14,072.0900 Cr | -5,306.1600 Cr | -7,905.8200 Cr | 11,943.5100 Cr | 983.1200 Cr | 10,268.7700 Cr | -2,128.5800 Cr | 10,929.0400 Cr | -1,030.3400 Cr | -3,613.9700 Cr | -183.9700 Cr |
| 2024-03-31 | 12,134.9800 Cr | -690.2000 Cr | -6,710.1600 Cr | 9,933.1700 Cr | 4,661.9200 Cr | 9,285.6500 Cr | -2,201.8100 Cr | 9,576.3800 Cr | -3,389.9300 Cr | -2,898.1700 Cr | 598.8100 Cr |
| 2023-03-31 | 4,959.3300 Cr | -7,943.6800 Cr | 2,376.0700 Cr | 2,873.7500 Cr | 115.4800 Cr | 4,623.7300 Cr | -2,085.5800 Cr | 9,408.4300 Cr | 5,129.6600 Cr | -2,518.8800 Cr | -1,202.2000 Cr |
| 2022-03-31 | 8,984.5400 Cr | -5,724.7400 Cr | -5,193.4600 Cr | 7,489.5000 Cr | -1,764.7800 Cr | 4,508.2500 Cr | -1,495.0400 Cr | 4,481.3200 Cr | -2,636.7100 Cr | -2,158.9200 Cr | 306.9500 Cr |
| 2021-03-31 | 6,170.3700 Cr | 536.2200 Cr | -5,980.4800 Cr | 5,000.2400 Cr | 596.4200 Cr | 6,273.0300 Cr | -1,170.1300 Cr | 2,799.3700 Cr | -4,489.6400 Cr | -1,559.4700 Cr | -1,080.2900 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 15,520.54 Cr | 6,569.43 Cr | 8,951.11 Cr | 0.5767 | 4,062.24 Cr | 3,368.81 Cr | 14.04 | 5,037.85 Cr | 0.2171 |
| 2025-09-30 | 14,478.31 Cr | 6,477.02 Cr | 8,001.29 Cr | 0.5526 | 3,367.08 Cr | 3,117.95 Cr | 13.00 | 4,996.97 Cr | 0.2154 |
| 2025-06-30 | 13,851.40 Cr | 6,316.97 Cr | 7,534.43 Cr | 0.5439 | 3,372.07 Cr | 2,278.63 Cr | 9.50 | 3,948.12 Cr | 0.1645 |
| 2025-03-31 | 12,958.84 Cr | 3,448.28 Cr | 9,510.56 Cr | 0.7339 | 6,153.90 Cr | 2,149.88 Cr | 9.00 | 3,446.39 Cr | 0.1659 |
| 2024-12-31 | 13,675.46 Cr | 2,740.54 Cr | 10,934.92 Cr | 0.7996 | 7,557.87 Cr | 2,903.38 Cr | 12.10 | 4,150.77 Cr | 0.2123 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 12,257.42 Cr | 15,623.01 Cr | 27,880.43 Cr | 15,447.70 Cr | 10,442.20 Cr | 60,136.43 Cr | 11,761.84 Cr | 103,706.50 Cr | 25,579.91 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 26,122.72 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -72,485.95 Cr |
| 2025-03-31 | 11,331.62 Cr | 13,656.10 Cr | 24,987.72 Cr | 13,046.11 Cr | 10,243.33 Cr | 52,624.47 Cr | 11,270.28 Cr | 92,100.58 Cr | 19,614.63 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 20,122.19 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -69,379.65 Cr |
| 2024-09-30 | 9,015.00 Cr | 11,107.19 Cr | 20,122.19 Cr | 12,989.39 Cr | 9,935.65 Cr | 46,105.45 Cr | 11,248.33 Cr | 88,115.66 Cr | 18,736.01 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 2,278.63 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 2,149.88 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 2,903.38 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 3,040.16 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 2,835.62 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2013-07-29 | July 29, 13 | 2:1 |
| 2010-11-25 | November 25, 10 | 5:1 |
| 2004-05-27 | May 27, 04 | 2:1 |
| 2003-01-13 | January 13, 03 | 2:1 |
| 2000-03-08 | March 08, 00 | 3:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,710.10 | ₹4,103,102,732,197.00 | ₹1,143,448.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,275.00 | ₹1,665,815,339,500.00 | ₹185,830.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹4,211.90 | ₹1,425,498,348,736.00 | ₹436,203.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,277.60 | ₹1,063,689,119,544.00 | ₹1,333,826.00 |
| Lupin Limited | LUPIN | ₹2,224.00 | ₹1,016,296,711,904.00 | ₹492,278.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹901.35 | ₹906,969,006,887.00 | ₹735,963.00 |
| Mankind Pharma Limited | MANKIND | ₹2,040.00 | ₹842,122,346,880.00 | ₹743,155.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,172.00 | ₹680,699,502,156.00 | ₹3,474,436.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,385.00 | ₹643,857,525,000.00 | ₹190,957.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,006.70 | ₹566,292,363,420.00 | ₹360,941.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,016.00 | ₹548,494,287,312.00 | ₹1,153,472.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,460.20 | ₹370,458,886,438.00 | ₹86,577.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,950.10 | ₹368,572,584,362.00 | ₹76,367.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,988.10 | ₹319,144,814,203.00 | ₹491,000.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,426.00 | ₹270,330,442,040.00 | ₹75,287.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,385.00 | ₹225,051,654,065.00 | ₹296,890.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,901.00 | ₹222,525,000,000.00 | ₹2,461.00 |
| Eris Lifesciences Limited | ERIS | ₹1,327.00 | ₹180,759,814,357.00 | ₹47,277.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,020.00 | ₹167,045,154,780.00 | ₹37,767.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹887.70 | ₹158,995,831,599.00 | ₹2,709,163.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹767.50 | ₹150,862,197,670.00 | ₹32,593.00 |
| Granules India Limited | GRANULES | ₹575.00 | ₹139,534,511,700.00 | ₹326,809.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹864.10 | ₹136,847,299,247.00 | ₹89,995.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,699.80 | ₹129,204,680,861.00 | ₹27,846.00 |
| Cohance Lifesciences Limited | COHANCE | ₹313.55 | ₹119,953,926,747.00 | ₹1,189,374.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹885.10 | ₹108,633,633,600.00 | ₹79,023.00 |
| Viyash Scientific Limited | VIYASH | ₹215.75 | ₹94,111,349,354.00 | ₹404,067.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,012.00 | ₹83,196,102,584.00 | ₹11,419.00 |
| Strides Pharma Science Limited | STAR | ₹875.00 | ₹80,651,124,750.00 | ₹271,177.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹484.00 | ₹74,101,396,072.00 | ₹461,345.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹713.80 | ₹64,704,035,602.00 | ₹89,021.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹326.00 | ₹63,759,672,016.00 | ₹216,364.00 |
| FDC Limited | FDC | ₹375.05 | ₹61,061,922,004.00 | ₹35,549.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹130.70 | ₹42,414,971,552.00 | ₹308,706.00 |
| Innova Captab Limited | INNOVACAP | ₹670.05 | ₹38,343,563,676.00 | ₹25,382.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹325.30 | ₹35,446,400,705.00 | ₹25,944.00 |
| Suven Life Sciences Limited | SUVEN | ₹153.00 | ₹34,803,522,000.00 | ₹158,488.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹670.00 | ₹33,981,800,350.00 | ₹77,280.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹369.25 | ₹33,701,447,500.00 | ₹93,464.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹1,921.00 | ₹31,771,447,815.00 | ₹4,665.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹285.00 | ₹28,580,514,210.00 | ₹33,828.00 |
Key Executives
Vice President, Head of Investor Relations & Strategic Projects
Abhishek Sharma
Gender: Not Specified
Year Born:
Head of Corporate Relations & CSR - India Regulatory Affairs
Azadar Hussain Asghar Mehdi Khan
Gender: Not Specified
Year Born: 1958
Chief Operating Officer, Head of Global Generics R&D, Business Devp., and Whole Time Director
Aalok Dilip Shanghvi
Gender: male
Year Born: 1984
Company Secretary & Compliance Officer
Anoop Deshpande
Gender: male
Year Born:
EVP & Chief Information Officer
Dheeraj Prasad Sinha
Gender: male
Year Born: 1971
Executive Chairman of the Board
Dilip Shantilal Shanghvi
Gender: male
Year Born: 1955
Director of Corporate Development
Kalyanasundaram Subramanian
Gender: male
Year Born: 1954
Managing Director
Kirti Wardhaman Ganorkar
Gender: male
Year Born: 1967
Chief Human Resources Officer
Suresh Rai
Gender: male
Year Born:
Executive Vice President & Chief Financial Officer
Jayashree Satagopan
Gender: female
Year Born: 1968
FAQs about Sun Pharmaceutical Industries Limited
Who is the CEO of the company?
The CEO is Dilip Shantilal Shanghvi.
What is the current market price of the stock?
The current price is ₹1,710.10.
What is the 52-week price range?
The range is ₹1548-1851.2.
What is the market capitalization of the company?
The market capitalization is ₹410,310.27 crores.
What is the dividend yield?
The dividend yield is 0.96%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 37.59.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Sun Pharmaceutical Industries Limited (ISIN: INE044A01036) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹410,310.27 crores and an average daily volume of 2,354,950 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹16.5.